Botanix Pharmaceuticals (ASX:BOT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Botanix Pharmaceuticals (ASX:BOT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notice of Allowance for US patent on Sofdra drug substance
Botanix granted US patent allowance for Sofdra drug substance, extending protection to 2040
Intention to Grant a European patent on Sofdra applicator
Botanix receives EPO Intention to Grant patent for Sofdra applicator technology
Application for quotation of securities - BOT
Notification of cessation of securities - BOT
Application for quotation of securities - BOT
Securities Trading Policy
Botanix announces change of address
Botanix appoints Chief Operating Officer
Botanix Q3 FY26 Investor Update Webinar Presentation
Botanix Quarterly Activities Report and Appendix 4C Q3 FY26
Botanix reports Sofdra prescription growth, $45M capital raise, API supply deal with Piramal, and tariff risk mitigation
Change of Director's Interest Notice x5
Botanix Webinar - 29 April - Registration Information
Notification regarding unquoted securities - BOT
Application for quotation of securities - BOT
Change of Director's Interest Notice x5
Completion of Security Purchase Plan
Notification of cessation of securities - BOT
Application for quotation of securities - BOT
Botanix reaches term sheet agreement with 2nd API supplier
Botanix Signs Term Sheet with Second API Supplier to Cut Costs and Secure Supply Chain
Ceasing to be a substantial holder